Aurora's wholly owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The company operates a 55,200-square-foot, state-of-the-art production facility in Mountain View county in Alberta, known as Aurora Mountain, and a second 40,000-square-foot high-technology production facility known as Aurora Vie in Pointe-Claire in Quebec on Montreal's West Island. In January, 2018, Aurora's 800,000-square-foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport, was licensed. Once at full capacity, Aurora Sky is expected to produce over 100,000 kilograms per annum of cannabis.
Cannabis Wheaton Income is a collective of entrepreneurs with a passion for the cannabis industry—past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.
Located in Denver, Colorado, Dixie Elixirs & Edibles (Dixie) has been producing award-winning THC-infused products since 2009. What began as a single flagship product, the Dixie Elixir (a THC-infused soda), has now expanded to over 30 different products across 100 SKUs, representing the industry's finest edibles, mints, energy shots, tinctures, and topicals. We handcraft every product with pure-extracted THC and a process we’re proud of. We go far above and beyond the mandated batch testing and triple lab test every product we sell. Because when it comes to cannabis, consistency, and accuracy are highly important. At Dixie, we’re a lot more than the producers of THC-infused products. We are the future of cannabis.
Emerald Health Therapeutics operates through Emerald Health Therapeutics Canada Inc. (EHTC), a wholly owned subsidiary and licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations. Through EHTC, Emerald is authorized to produce and sell dried cannabis and cannabis oil for medical purposes. It operates an indoor facility in Victoria, B.C., and is building a 500,000-square-foot greenhouse on 32 acres in Metro Vancouver, with expansion potential to one million square feet to serve the anticipated legal Canadian adult-use cannabis market starting in 2018.
Established in 2016, Forma builds businesses in legal medical cannabis markets around the world. With offices in London and Los Angeles, we take an international view of the cannabis market, and operate in three areas. Retail and Cultivation: We have acquired a series of medical cannabis assets across cultivation, manufacturing and distribution in the Western United States. Pharmaceutical and Life Sciences: We are designing research programs with world-renowned academic institutions into the medical properties of cannabis, with a view to ultimately initiating clinical trials and bringing new cannabinoid-based medicines to market. Anthos Ventures: We invest in ambitious entrepreneurs and iconic businesses shaping the cannabis industry.
Emblem, through its wholly owned subsidiary Emblem Cannabis Corp., is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals -- cannabis production, patient education centre and pharmaceutical dosage form development.
Halo Labs is Oregon's leading manufacturer of cannabis oil and concentrates with a +20% share. Our initial business in Oregon is currently running at US$1.0MM+ net revenue per month, operating a 16,000 sqf. Class 1 Division 1 manufacturing facility. In California we have a manufacturing facility licensed by Cathedral City and a partnership with a large dispensary chain. In Nevada a fully licensed manufacturing facility planned build out and a private label deal in place with dispensary partner. In Canada a processing facility and multi-acre grow in design to support proposed JV with large Canadian LP.
Khiron Life Sciences Corp. is a Canadian integrated medical cannabis company with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages, and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America. We focus on developing and commercializing top quality medically-validated products, and promoting breakthrough research for the newly created medical cannabis industry in Colombia and Latin America.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Toronto, Canada, and Munich, Germany, with production facilities in Langton, Ont., Canada, where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under a federal licence from the government of Canada, and Dresden, Saxony, Germany. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000-square-foot (87,515 square metres) buildout, capable of producing 95,000 kilograms of dry cannabis flower per year to support existing and future patient growth.
Namaste is the largest on-line retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the United Kingdom, Canada and Germany, and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales (under the ACMPR (Access to Cannabis for Medical Purposes Regulations)), is pursuing a new revenue vertical in on-line retail of medical cannabis in the Canadian market.
Organigram's wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest-quality, condition-specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, N.B., and the company is regulated by the Access to Cannabis for Medical Purposes Regulations (ACMPR).
Phivida's mission is to lead the alternative health care sector as the benchmark standard in premium cannabinoid infused foods, beverages and clinical products. Using nanoencapsulation technology, Phivida converts phytocannabinoids into water soluble delivery format, enhancing bioavailability, and timed released within the body. Phivida's encapsulated cannabinoids are infused into functional beverages, foods and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health conditions, from chronic pain to terminal diseases.
Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun-grown cannabis through its wholly owned subsidiary 7Acres. 7Acres is a federally licensed producer of medical cannabis pursuant to the ACMPR (Access to Cannabis for Medical Purposes Regulations), operating inside a 342,000-square-foot hybrid greenhouse facility. The hybrid greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint.
Euromonitor International is the world's leading independent provider of strategic market research. We create data and analysis on thousands of products and services around the world. The legalization of cannabis, both in the US and globally, is reshaping the tobacco and alcoholic drinks industries. Euromonitor International has published a series of reports and webinars exploring the evolving legal cannabis landscape; addressing the emerging trends; and assessing the impact and potential on businesses.